1. Denmark Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Demant A/S

Demant A/S

47.66
EUR
-0.60
(-1.24%)
7.39BMarket Cap
Feb 09Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
31.65
33.6
39.48
45.51
51.41
55.94
61.37
60.34
76.25
87.19
96.81
103.21
108.71
- -
Basic EPS, GAAP
4.54
4.77
5.32
5.53
6.84
7.32
6
4.68
10.7
9.21
8.04
10.99
7.31
- -
Free Cash Flow per Basic Share
3.1
4
4.44
5.16
6.08
5.03
6.48
8.82
12.21
7.51
16.24
15.2
14.17
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
17.91
20.48
24.31
26.86
29.38
28.75
31.74
34.39
34.66
38.36
41.97
44.9
46.67
53.3
Tangible Book Value per Share
5.11
5.8
1.95
0.74
2.12
-3.33
-3.91
-3.56
-10.17
-18.02
-19.42
-25.83
-49.96
-46.74
Basic Weighted Avg Shares
283
278
270
264
257
249
244
240
235
226
223
217
211
210
Sales/Revenue/Turnover
8,959
9,346
10,665
12,002
13,189
13,937
14,946
14,469
17,905
19,705
21,601
22,419
22,971
- -
Operating Margin (%)
18.83
18.15
17.16
15.51
17.33
17.21
13.6
7.08
19.79
15.66
20.55
19.2
17.08
- -
Depreciation Expense
292
294
325
404
404
446
959
1,048
1,065
1,176
1,293
1,435
1,519
- -
Net Income, GAAP
1,285
1,326
1,436
1,459
1,754
1,823
1,462
1,121
2,513
2,082
1,795
2,387
1,545
- -
Effective Tax Rate (%)
22.72
21.53
20.45
20.48
21.01
22.72
23.23
15.12
21.67
22.24
24.62
22.17
23.67
- -
Profit Margin (%)
14.34
14.19
13.46
12.16
13.3
13.08
9.78
7.75
14.04
10.57
8.31
10.65
6.73
- -
Working Capital
-887
-1,133
-321
-705
-363
-1,481
-1,930
-687
-3,087
-1,547
2,522
3,826
2,652
-2,220
LT Debt
81
9
2,080
1,960
2,339
2,164
4,058
4,936
4,405
7,864
12,216
14,591
18,982
13,126
Total Equity
5,056
5,584
6,500
6,966
7,433
7,059
7,645
8,279
7,981
8,562
9,338
9,644
9,919
11,317
Return on Invested Capital (%)
17.72
15.81
14.27
12.66
14.34
14.3
10.34
7.4
15.65
11.63
14.27
13.83
10.68
- -
Return on Capital (%)
17.58
15.64
14.14
12.45
14.13
13.89
9.94
6.92
14.12
10.38
9.24
11.78
7
- -
Return on Common Equity (%)
28.19
24.92
23.76
21.68
24.38
25.18
19.91
14.11
30.97
25.18
20.15
25.37
15.92
- -

Capital Structure

DKK

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
911
2,006
7,156
LT Borrowings
13,239
16,411
10,571
LT Finance Leases
2,029
2,571
2,555
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
211
211
211
Market Capitalization
- -
45,263
55,229

Working Capital

DKK

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
10,203
10,075
10,205
Cash, Cash Equivalents & STI
1,142
1,330
1,496
Accounts Receivable, Net
3,503
3,765
4,217
Inventories
2,542
2,620
2,807
Total Current Liabilities
5,794
7,423
12,425
Payables & Accruals
- -
- -
- -
ST Debt
911
2,006
7,156
Deferred Revenue
- -
- -
- -

Growth Rates

DKK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.43%
3.77%
2.85%
Free Cash Flow
15.84%
18.01%
-9.27%
Net Income, GAAP
7.36%
18.19%
-35.27%
Sales/Revenue/Turnover
8.18%
9.93%
2.46%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

DKK

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
22,419
2025
- -
- -
22,971
2026
- -
- -
- -

Semi-annual Earnings Per Share

DKK

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
10.99
2025
- -
- -
7.31
2026
- -
- -
- -

Semi-annual Dividends Per Share

DKK

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Søren Nielsen
Full Time Employees
26,704
Sector
Health technology
Industry
Medical specialties
Address
Kongebakken 9 Smorum ZE Denmark 2765
IPO Date
May 1, 1995
Website
demant.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Demant A/S functions as an international leader in hearing healthcare, with a presence spanning Europe, North America, Asia, and the Pacific. The company centers its operations around three principal areas: Hearing Aids, Hearing Care, and Diagnostics. Its Hearing Aids division manufactures innovative solutions under brands such as Oticon, Bernafon, Sonic, and Philips Hearing Solutions. The Hearing Care segment encompasses a global network of clinics, including Audika and HearingLife, delivering personalized audiological services. Additionally, the Diagnostics area supplies a range of equipment for hearing and balance assessment from brands like MAICO, Interacoustics, and Grason-Stadler. While primarily focused on hearing health, Demant also offers audio technology for professional and gaming environments through its EPOS brand. The company, which originated as William Demant Holding A/S before its name change in March 2019, traces its roots back to 1904 and is based in Smørum, Denmark.

Company News

Company News APIChatGPT

  • zacks.com

    Best Momentum Stock to Buy for October 2nd

  • zacks.com

    New Strong Buy Stocks for October 2nd

  • seekingalpha.com

    Demant A/S (WILYY) Q2 2026 Earnings Call Transcript

  • defenseworld.net

    Demant A/S (OTCMKTS:WILLF) Short Interest Up 20.6% in March

  • defenseworld.net

    Demant A/S (OTCMKTS:WILLF) Sees Significant Increase in Short Interest

  • seekingalpha.com

    Demant A/S (WILYY) Q4 2025 Earnings Call Transcript

  • defenseworld.net

    Demant A/S (OTCMKTS:WILLF) Shares Up 2.1% – Still a Buy?

  • defenseworld.net

    Demant A/S (OTCMKTS:WILLF) Stock Price Up 0.2% – Time to Buy?

  • seekingalpha.com

    Demant A/S (WILLF) Q2 2025 Earnings Call Transcript

  • zacks.com

    Is Demant (WILYY) Stock Undervalued Right Now?

  • seekingalpha.com

    Demant A/S (WILLF) Q4 2024 Earnings Call Transcript

  • zacks.com

    Best Momentum Stocks to Buy for March 26th

  • zacks.com

    New Strong Buy Stocks for March 26th

  • zacks.com

    New Strong Buy Stocks for March 19th

  • zacks.com

    Best Momentum Stocks to Buy for March 11th

  • zacks.com

    New Strong Buy Stocks for March 11th

  • zacks.com

    Best Momentum Stocks to Buy for March 7th

  • zacks.com

    New Strong Buy Stocks for March 7th

  • zacks.com

    Best Momentum Stocks to Buy for March 4th

  • zacks.com

    New Strong Buy Stocks for March 4th